Press Announcements > FDA research to help speed development of Zika virus vaccines and therapeutics
For Immediate Release:
Nov. 17, 2016
Tara Goodin, 240-402-3157, email@example.com
Lauren Smith Dyer, 301-348-1888, firstname.lastname@example.org
FDA research to help speed development of Zika virus vaccines and therapeutics
Neonatal mouse model provides a new platform for Zika virus research
A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics. Published today in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.